Regeneus Ltd (ASX:RGS) Commences Canine Cancer Vaccine Trial
Sydney, Nov 26, 2015 AEST (ABN Newswire) - Regeneus (
ASX:RGS), a clinical-stage regenerative medicine company, announced today the commencement of a trial of its cancer vaccine technology, Kvax, in combination with chemotherapy as a treatment for canine lymphoma. Veterinary oncologists at the Small Animal Specialist Hospital (SASH) in Sydney will conduct the trial. SASH is a leading specialist veterinary referral hospital which is often featured as the referral hospital on the television program Bondi Vet. The trial will use Kvax together with chemotherapy to seek to extend remission times for 45 dogs with lymphoma. All dogs will be definitively diagnosed for B-cell lymphoma and will undergo chemotherapy.
Cardinal Resources Limited (ASX:CDV) announced the results of 13 RC drill holes which have been received for the Namdini Project ("Namdini").
HIGHLIGHTS
- Very wide gold intersections found in latest RC drilling at Namdini
- Strike length extended to ~900m
- 13 RC drill holes on 5 sections include:
- 83m @ 1.41 g/t from 13m vertical depth
- 67m @ 1.78 g/t from surface
- 51m @ 1.02 g/t from 35m vertical depth
- 48m @ 1.15 g/t from 19m vertical depth
"The width of these new zones of gold mineralisation ranges from ~120m to ~230m across strike. "Wide gold intersections range from surface to very shallow depths which further enhances the gold potential of this project". The mineralised zones shown on the sections range between 128m to 230m across strike, indicating wide zones of gold mineralisation.
Altech Chemicals Limited (ASX:ATC) provided an update on the detailed design work that is currently underway for its proposed high purity alumina (HPA) project. Detailed design commenced in September 2015, following the appointment of General Manager Operations Dr Jingyuan Liu and is being undertaken with the assistance of Simulus Engineering, a Perth based multidiscipline engineering consultancy and M+W Group, the EPCM contractor for the project. The detailed design work also includes consideration of optimisation opportunities for process flow design, plant layout, capital equipment and operating costs.
Contact
Dorothy Zhao
T: +61-2-8205-7338
W: www.abnnewswire.com
| ||
|
